Press Release: Gynecologic Cancer Awareness Movement (GCAM) to be Featured on Times Square “Super Screen”

The Gynecologic Cancer Foundation’s Gynecologic Cancer Awareness Movement (GCAM) will get a huge boost this holiday season when its message appears more than 575 times between Thanksgiving and New Years Day on theCBS “Super Screen” in the heart of New York’s Times Square.

The 15-second GCAM public service ad will appear once an hour for 18 hours each day between today in time for the Macy’s Thanksgiving Day Parade and January 1st. The “Super Screen,” strategically located at 42nd Street between 7th and 8th Avenues, measures 26’ by 20’ for a total 520 square feet of high-impact space with 1.5 million viewers expected each day. The Foundation acknowledges Neutron Media’s support.

“This year alone, 75,000 women will be diagnosed with, and 28,000 women will die from, a reproductive cancer,” said GCF Chairman Dr. David Gershenson. “We are grateful for this significant opportunity to raise awareness about the prevention, early detection and optimal treatment of gynecologic cancer.”

See the video ad here.

For more information about the Gynecologic Cancer Foundation, visit GCF’s Women’s Cancer Network

The Gynecologic Cancer Foundation was established by the Society of Gynecologic Oncologists in 1991 to dramatically increase the amount of funding available to support research and to increase knowledge and awareness about the prevention, early detection and optimal treatment of all types of reproductive cancer. As GCF’s 20th anniversary approaches, the organization is committed to expanding its outreach and mission to women not yet diagnosed with a gynecologic cancer to alert them to methods of prevention and early detection of cancers unique to women.


Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.


Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.


The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.


The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.